Trial intelligence / Profile preview

Intravenous labetalol for pain and anxiety control during bone marrow aspiration and biopsy

IRCT20191201045563N1Phase 2Completed

Sponsor
Semnan University of Medical Sciences
Start
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of labetalol in anxiety disorder, sponsored by Semnan University of Medical Sciences. Started Dec 2019; status: completed.

02

Drugs

labetalol
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on IRCT20191201045563N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191201045563N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call